Patients with VEXAS diagnosed in a Danish tertiary rheumatology setting have highly elevated inflammatory markers, macrocytic anaemia and negative autoimmune biomarkers

MLA

Ellen-Margrethe Hauge, et al. “Patients with VEXAS Diagnosed in a Danish Tertiary Rheumatology Setting Have Highly Elevated Inflammatory Markers, Macrocytic Anaemia and Negative Autoimmune Biomarkers.” RMD Open, vol. 8, no. 2, Sept. 2022. EBSCOhost, https://doi.org/10.1136/rmdopen-2022-002492.

APA

Ellen-Margrethe Hauge, Anne Troldborg, Fruzsina Szabados, Mads Nyhuus Bendix Rasch, Jens Magnus Bernth Jensen, & Kirstine Overgaard Nielsen. (2022). Patients with VEXAS diagnosed in a Danish tertiary rheumatology setting have highly elevated inflammatory markers, macrocytic anaemia and negative autoimmune biomarkers. RMD Open, 8(2). https://doi.org/10.1136/rmdopen-2022-002492

Chicago

Ellen-Margrethe Hauge, Anne Troldborg, Fruzsina Szabados, Mads Nyhuus Bendix Rasch, Jens Magnus Bernth Jensen, and Kirstine Overgaard Nielsen. 2022. “Patients with VEXAS Diagnosed in a Danish Tertiary Rheumatology Setting Have Highly Elevated Inflammatory Markers, Macrocytic Anaemia and Negative Autoimmune Biomarkers.” RMD Open 8 (2). doi:10.1136/rmdopen-2022-002492.